EDGAR Filing Documents for 0001140361-17-022538

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001140361-17-022538

Filing Date

2017-05-26

Accepted

2017-05-26 16:22:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	forms3.htm	S-3	242420
2	EXHIBIT 5.1	ex5_1.htm	EX-5.1	24074
3	EXHIBIT 12.1	ex12_1.htm	EX-12.1	38216
4	EXHIBIT 23.1	ex23_1.htm	EX-23.1	2587
5	EXHIBIT 24.1	ex24_1.htm	EX-24.1	11967
6		image0.jpg	GRAPHIC	73519
7		image00002.jpg	GRAPHIC	4432
	Complete submission text file	0001140361-17-022538.txt		427820

Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850

Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300

REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)